Events

XIII IPLS, Madrid

Event Details

  • Location: NH Collection Eurobuilding Hotel, Madrid
  • Dates: Thursday 28th September to Friday 29th September 2017
  • Price: £
    (Non-Members: £1025.00)

New Partnering System now LIVE! All pre-booked delegates able to upload their own profile and arrange personal one-to-one meeting diary with automatic scheduling.

Please visit Meeting Mojo to access this new partnering system, registered delegates will have received their passwords via email.

‘The Role of Business Development in Changing Global Times’

We are pleased to announce that we will be returning to Madrid for XIII International Pharma Licensing Symposium (IPLS) on Thursday 28th & Friday 29th September 2017.

For the first time the programme features specific time set aside for private partnering meetings that can be arranged using a NEW improved partnering system being introduced in 2017. This will allow delegates to create their own profile and mange their own meeting requests and schedule in advance of the event.

The current programme is available below and please continue to visit this page as further presentation titles and speakers are confirmed.

Event Highlights

  • Welcome Networking Reception on Wednesday evening (included in delegate fee)
  • NEW Partnering System to Arrange Meeting Schedule
  • Specific Private Meeting Area
  • 6 Presentation Sesssions (topics as below)
  • Networking Reception and Gala Dinner at Casino de Madrid on Thursday evening (included in delegate fee)
  • Access to Authorised Presentations Post-Event
  • Opportunity to Network with BD Colleagues from Across Europe

Topics being discussed during this event will include:

  • External Factors Impacting upon the Pharma Industry – Political, Financial & Regulatory
  • The Impact of Digital Technology – Changes in Strategy, Methodology and Marketing
  • The Role of BD in this new era – the Interaction between Alliance Management & BD
  • The Increasing Importance of OTC – Local v Global Brands
  • Risk or Opportunity – IP & Market Access
  • Financial Evaluation & Business Models- Valuation to Assets or Assets to Valuation?

xiii-international-pharma-licensing-symposium-ipls

Event Sponsors

Event Schedule

Wednesday 27th September

3pm Pre-Arranged One-to-One Meetings
Organised using Partnering System
6pm - 7.30pm Welcome Drinks Reception
NH Collection Eurobuilding Hotel

Thursday 28th September

9am Registration
EXTERNAL FACTORS IMPACTING THE PHARMACEUTICAL INDUSTRY
9.30am Welcome Introduction & Keynote Presentation
JUAN LOPEZ-BELMONTE ENCINA
Vice-President, Farmaindustria
&
CEO, Laboratorios Rovi
9.45am Industry Update and Analysis
ANTONIO IERVOLINO
Head of Forecasting, Evaluate
10.15am Brexit - Impact on Pharmaceutical Industry?
UK View - Situation Post Brexit
European View - Impact on Strategies
JO PISANI
Partner, UK Pharma and Lifesciences Consulting Leader, PwC Strategy&
&
SERGIO NAPOLITANO
Legal, Trade and Public Affairs Director, Medicines for Europe
11am Break
THE IMPACT OF DIGITAL TECHNOLOGY
11.30am Case Study - Sanofi & Voluntis
PIERRE LEURENT, Voluntis
12pm Digital Transformation in the Pharmaceutical Sector
NÉSTOR SANCHEZ
Digital Transformation Manager, Indra
12.30pm Big Pharma Experience of Digital Technologies and Impact on Strategies
1pm Lunch
THE ROLE OF BUSINESS DEVELOPMENT
2pm Panel Discussion - Business Development and Alliance Management
Good Partnering Practices (GPPs) Conceived under the Leadership of Swiss HLG
CHAIR
ANTHONY HOERNING
Strategic Transactions Advisory

PANEL
LAURENCE DE SCHOULEPNIKOFF, Head of Strategy, Transaction and Legal, Stragen Pharma
JOERG MAYER, Director Business Development Europe, LTS Lohmann
SARA MAZZUOCCOLO, Head of Partnering & Alliance, APR Applied Pharma Research
HENNING MENNENOEH, Weitnauer Advokaten
4pm Pre-Arranged One-to-One Meetings
Organised using Partnering System
6.30pm Transport to Casino de Madrid
7pm Networking Reception
8pm Gala Dinner
10.30pm Return Transport to NH Collection Eurobuilding Hotel

Friday 29th September

THE INCREASING IMPORTANCE OF THE OTC AND OTHER BUSINESS AREAS
9am Prescription to OTC Switching
9.30am Case Study: Nestlé Health Science - When Nutrition becomes Therapy
KIM BILL
Vice President, Global Business Development & Licensing, Nestlé Health Science
10am Emerging Trends in OTC & Why Big Pharma Should Play There
NICHOLAS HALL
Chairman & CEO, Nicholas Hall Group of Companies
10.30am Break
RISK OR OPPORTUNITY? IP & MARKET ACCESS
11am IP Management/Protection
LIVA VILLA
European Patent Attorney, ADV IP
11.30am Market Access - European Trends
PROFESSOR MONDHER TOUMI
CEO, Creativ-Ceutical
12pm Break
12.30pm FINANCIAL EVALUATION & BUSINESS MODELS
12.30pm From Valuation to Assets or From Assets to Valuation?
ZAKI SELLAM
Managing Director, ESN Life Sciences
1pm Business Models
PAUL PAY
Chief Business Development Officer, Norgine
1.30pm Lunch & CLOSE

Venue & Accommodation

Full Venue Address

NH Collection Eurobuilding
Padre Damián, 23
28036 Madrid
Spain

Accommodation Details

Discounted accommodation rates have been negotiated with the NH Collection Eurobuilding Hotel for the duration of this event. These rates can be booked directly with the hotel by clicking the following link:

DISCOUNTED HOTEL RATES